Olifant Fund, Ltd., 10% Owner at Clarus Therapeutics Holdings, Inc. (CRXT), sold 127,360 shares at $9.20 ($1.2M) on 2021-09-17, disclosed to the SEC on 2021-09-21.
Open-market sale of $1.2M CRXT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.